PD Dr. Markus Eckstein

Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie Institute of Pathology

Prospective Evaluation of All-lesion Versus Single-lesion Radiotherapy in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors (2020) Schubert P, Rutzner S, Eckstein M, Frey B, Schweizer C, Haderlein M, Lettmaier S, et al. Journal article Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8 (2020) Hecht M, Gostian AO, Eckstein M, Rutzner S, von der Grün J, Illmer T, Hautmann MG, et al. Journal article Analysis of CXCL9, PD1 and PD-L1 mRNA in stage T1 non-muscle invasive bladder cancer and their association with prognosis (2020) Kubon J, Sikic D, Eckstein M, Weyerer V, Stöhr R, Neumann A, Keck B, et al. Journal article Assessment of prognostic and predictive value of FGFR alterations (FGFRa) in a real-world cohort of patients (pts) with high-risk pT1 non-muscle-invasive bladder cancer (NMIBC) (2020) Breyer J, Monga M, Mayr R, Otto W, Burger M, Eckstein M, Stöhr R, et al. Conference contribution Expression of AR-V7 (Androgen receptor variant 7) protein in granular cytoplasmic structures is an independent prognostic factor in prostate cancer patients (2020) König P, Eckstein M, Jung R, Abdulrahman A, Guzman J, Weigelt K, Serrero G, et al. Journal article Progranulin (GP88) is an independent prognostic factor for prostate cancer patients (2020) Taubert H, Abdulrahman A, Eckstein M, Jung R, Guzman J, Weigelt K, Serrero G, et al. Conference contribution Profiling intratumoral heterogeneity of bladder cancer subtypes at the single-cell level using machine-learning assisted histopathology. (2020) van Rhijn BWG, Mertens L, Mayr R, Bostrom P, Marques M, Van Leenders G, Gotz S, et al. Conference contribution Uninflamed immunologic microenvironment of muscle-invasive bladder cancer associates with activating FGFR3 gene alterations. (2020) Weyerer V, Stöhr R, Strissel P, Strick R, Bolenz C, Hartmann A, Erben P, Eckstein M Conference contribution Results of the first prototypical Ring Trial of QuIP for PD-L1 Expression in Urothelial Carcinomas (2020) Sommer U, Baretton G, Hartmann A, Eckstein M, Schwamborn K, Weichert W, Kristiansen G, et al. Journal article, Editorial Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy (2020) Eckstein M, Strissel P, Strick R, Weyerer V, Wirtz R, Pfannstiel C, Wullweber A, et al. Journal article